Innosyn was established in 2012,concentratesits business on producing and researching of pharmaceutical intermediates high-tech company.Innosyn's headquarter locates in PingShan Shenzhen, where it's well equipped with 4000㎡ R&D Center, integrated equipments and systems on R&D and Quality Test system. Meanwhile Innosyn has modern production facilities in Guangdong and Guangxi province, which occupy full approval of EH&S and well organized Quality Management System. Basing on brilliant innovative talent and proprietary technology, Innosyn is able to offer customers all kinds of solution on new product development, test as well as professional service like CRO,CDMO etc.
Year Established: 2012
Total Number of Staff: less than 10 person
Business Type: Manufacturer
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
![(4 s) - 3 - [5 - (4 - fluorinated phenyl) - 1, 5-2 oxygen generation amyl] - 4 - phenyl - 2 - pbo al](https://eimg.pharmasources.com/image/20210917/rp5QclIUImjYMND1uuWFDFXTkHJ0nePIcCbh7dzN.jpeg)
(4 s) - 3 - [5 - (4 - fluorinated phenyl) - 1, 5-2 oxygen generation amyl] - 4 - phenyl - 2 - pbo al
9 - fluorene methyl - N - succinimide base carbonate
![4 - [(2, 4 - dimethoxy phenyl) (FMOC - amino) methyl] benzene acetic acid oxygen](https://eimg.pharmasources.com/image/20210917/w7MezSaFXbmH7Amg90goV8XWwIgo2U2tLgwbn872.jpeg)
4 - [(2, 4 - dimethoxy phenyl) (FMOC - amino) methyl] benzene acetic acid oxygen
2 - (1, 3-2 - bok - three fluorinated methyl sulfonyl) guanidine